Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

LEADS BIOLABS-B

62.450
-1.700-2.65%
Volume:1.60M
Turnover:104.71M
Market Cap:12.43B
PE:-44.53
High:68.000
Open:64.500
Low:62.050
Close:64.150
52wk High:97.500
52wk Low:44.720
Shares:199.00M
HK Float Shares:198.00M
Volume Ratio:1.38
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.402
ROE:-27.61%
ROA:-9.92%
PB:8.47
PE(LYR):-44.53
PS:60.50

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
LEADS BIOLABS-B
Exchange:
SEHK
Establishment Date:
2012
Employees:
244
Office Location:
Building 03,Floor 8,18E, Jialingjiang Street,Nanjing,Jiangsu Province,China
Website:
http://www.leadsbiolabs.com
Zip Code:
210019
Phone:
- -
Fax:
- -
Introduction:
Nanjing Leads Biolabs Co Ltd is a China-based company primarily engaged in the discovery, development, and commercialization of new therapies in oncology, autoimmune, and other severe diseases. The Company’s main drug candidates include LBL-024, LBL-034, LBL-033, LBL-007 and others. The company's LBL-024 is mainly used to treat extra-pulmonary neuroendocrine carcinoma (EP-NEC), small cell lung cancer (SCLC), biliary tract carcinoma (BTC), non-small-cell lung cancer (NSCLC), esophageal squamous cell carcinoma (ESCC), hepatocellular carcinoma (HCC), gastric cancer (GC) and other solid tumors. The Company has also developed multiple proprietary technology platforms, including LeadsBod platform (a CD3 T-cell engager platform), X-body platform (a 4-1BB engager platform) and several other bispecific antibody and fusion protein platforms. The Company mainly conducts its business in the domestic market.

Directors

Name
Position
KANG Xiao Qiang
Chairman of the Board,Executive Director,Member of the Nomination Committee
ZUO Hong Gang
Executive Director
LAI Shou Peng
Executive Director
CHEN Ren Hai
Director,Audit Committee Member
ZHANG Yin Cheng
Director,Member of the Remuneration and Assessment Committee
WU Feng Lan
Director
ZHANG Hong Bing
Independent Director,Chairman of the Nomination Committee
DU Yi Long
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
DU Ji Liu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Chairman

Shareholders

Name
Position
KANG Xiao Qiang
CEO,General Manager
LING Hong
Vice General Manager,Chief Science Officer
ZUO Hong Gang
CFO,Board Secretary,Corporate Secretary
JIAN Xue Gen
Corporate Secretary
LAI Shou Peng
Other Senior Executives,Other Senior Executives
CAI Sheng Li
Other Senior Executives